MediPharm Labs Corp. Remains A Top Cannabis Stock
MediPharm Labs Corp (OTCMKTS:MEDIF, TSX:LABS) has consistently been one of the top-performing stocks throughout 2019. On May 22, it hit an intra-day high of $6.56, for a then-year-to-date gain of 367%. It closed out June at $3.96, up 240%, making it one of the best-performing pot stocks in the first half of the year.
Despite concerns of the trade war between the U.S. and China, the broader market selloffs, and a swoon in marijuana stocks, MediPharm remains bullish. And having graduated to the Toronto Stock Exchange, significantly improving its visibility, the company's outlook for the back half of 2019 remains.
Den vollständigen Artikel lesen ...
MediPharm Labs Corp (OTCMKTS:MEDIF, TSX:LABS) has consistently been one of the top-performing stocks throughout 2019. On May 22, it hit an intra-day high of $6.56, for a then-year-to-date gain of 367%. It closed out June at $3.96, up 240%, making it one of the best-performing pot stocks in the first half of the year.
Despite concerns of the trade war between the U.S. and China, the broader market selloffs, and a swoon in marijuana stocks, MediPharm remains bullish. And having graduated to the Toronto Stock Exchange, significantly improving its visibility, the company's outlook for the back half of 2019 remains.
Den vollständigen Artikel lesen ...